[1]
|
R. Griffiths, W. Richards, M. Johnson, U. McCann and R. Jesse, “Mystical-Type Experiences Occasioned by Psilocybin Mediate the Attribution of Personal Meaning and Spiritual Significance 14 Months Later,” Journal of Psychopharmacology, Vol. 22, No. 6, 2008, pp. 621-632.
doi:10.1177/0269881108094300
|
[2]
|
U. Lindequist, T. H. J. Niedermeyer and W. D. Julich, “The Pharmacological Potential of Mushrooms—Review,” Evidence-Based Complementary and Alternative Medicine, Vol. 2, No. 3, 2005, pp. 285-299.
doi:10.1093/ecam/neh107
|
[3]
|
J. W. Bennett and M. Klich, “Mycotoxins,” Clinical Microbiology Reviews, Vol. 16, No. 3, 2003, pp. 497-516.
doi:10.1128/CMR.16.3.497-516.2003
|
[4]
|
C. Hsieh and F. Yang, “Reusing Soy Residue for the Solid-State Fermentation of Ganoderma lucidum,” Bioresource Technology, Vol. 91, No. 1, 2004, pp. 105-109.
doi:10.1016/S0960-8524(03)00157-3
|
[5]
|
J. L. Mau, H. C. Lin and C. C. Chen, “Non-Volatile Components of Several Medicinal Mushrooms,” Food Research International, Vol. 34, No. 6, 2001, pp. 521-526.
doi:10.1016/S0963-9969(01)00067-9
|
[6]
|
Y. Masuda, Y. Murata, M. Hayashi and H. Nanba, “Inhibitory Effect of MD-Fraction on Tumor Metastasis: Involvement of NK Cell Activation and Suppression of Intercellular Adhesion Molecule (ICAM)-1 Expression in Lung Vascular Endothelial Cells,” Biological & Pharmaceutical Bulletin, Vol. 31, No. 6, 2008, pp. 1104-1108.
doi:10.1248/bpb.31.1104
|
[7]
|
A. T. Borchers, A. Krishnamurthy, C. L. Keen, F. J. Meyers and M. E. Gershwin, “The Immunobiology of Mushrooms,” Experimental Biology and Medicine, Vol. 233, No. 3, 2008, pp. 259-276. doi:10.3181/0708-MR-227
|
[8]
|
T. Pillai, C. Nair and K. Janardhanan, “Polysaccharides Isolated from Ganoderma Lucidum Occurring in Southern Parts of India, Protects Radiation Induced Damages Both in Vitro and in Vivo,” Environmental Toxicology and Pharmacology, Vol. 26, No. 1, 2008, pp. 80-85.
|
[9]
|
C. N. Harold and D. G. Thomas, “Antimicrobial Chemotherapy,” Medical Microbiology, 4th Edition, University of Texas Medical Branch, Galveston, 1996.
|
[10]
|
C. Perez, M. Pauli and P. Bazerque, “An Antimicrobial Assay by the Agar Well Diffusion Method,” Acta Biologae et Medicine Experimentalis, Vol. 15, 1990, pp. 113-115.
|
[11]
|
A. E. Sofowora and A. Odebiyi, “Medicinal Plants and Traditional Medicinal in Africa,” 2nd Edition, Spectrum Books Ltd., Ibadan, 1993, pp. 134-156.
|
[12]
|
J. H. Zar, “Biostatistical Analysis,” Prentice-Hall, Upper Saddle River, 1984.
|
[13]
|
B. Boh, M. Berovic, J. Zhang and L. Zhi-Bin, “Ganoderma lucidum and Its Pharmaceutically Active Compounds,” Biotechnology Annual Review, Vol. 13, 2007, pp. 265-301. doi:10.1016/S1387-2656(07)13010-6
|
[14]
|
B. U. Shamaki, U. K. Sandabe, I. A. Fanna, O. O. Adamu, Y. A. Geidam, I. I. Umar, M. S. Adamu, “Proximate Composition, Phytochemical and Elemental Analysis of Some Organic Solvent Extract of The Wild Mushroom Ganoderma lucidum,” Journal of Natural Sciences Research, Vol. 2, No. 4, 2012.
|
[15]
|
S. Sekaran, S. Elumalai, B. Ramalingam and K. Devendiran, “Evaluation of Antibacterial and Antifungal Activity of Ganoderma lucidum (curtis) p. Karst Fruit Bodies Extracts,” World Journal of Science and Technology, Vol. 1, No. 6, 2011, pp. 8-11.
|